GWMI
INDV icon

Guardian Wealth Management (Illinois)’s Indivior Pharmaceuticals INDV Stock Holding History

Guardian Wealth Management (Illinois)’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-160
Closed -$1.52K – 132
2025
Q1 		$1.52K Hold
160
– – ﹤0.01% 209
2024
Q4 		$1.99K Hold
160
– – ﹤0.01% 213
2024
Q3 		$1.56K Hold
160
– – ﹤0.01% 226
2024
Q2 		$2.58K Hold
160
– – ﹤0.01% 207
2024
Q1 		$3.43K Hold
160
– – ﹤0.01% 193
2023
Q4 		$2.44K Hold
160
– – ﹤0.01% 213
2023
Q3 		$3.69K Buy
+160
New +$3.65K ﹤0.01% 188

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Guardian Wealth Management (Illinois)'s INDV Position: Q2 2025 in Review

Guardian Wealth Management (Illinois) sold out of Indivior Pharmaceuticals (INDV) in Q2 2025, closing a stake of 160 shares — an estimated $1.52K sold.

Guardian Wealth Management (Illinois) first reported a position in INDV in Q3 2023 and held it in 7 quarters. The position peaked at $3.69K in Q3 2023. 120 funds tracked by Wall St. Rank hold INDV as of Q2 2025.

  • Guardian Wealth Management (Illinois) reported no remaining Indivior Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Guardian Wealth Management (Illinois) sold 160 Indivior Pharmaceuticals shares in Q2 2025, an estimated $1.52K.
  • Guardian Wealth Management (Illinois) first reported a position in Indivior Pharmaceuticals in Q3 2023 and held it in 7 quarters.
  • Guardian Wealth Management (Illinois)'s Indivior Pharmaceuticals position peaked at $3.69K in Q3 2023.
  • 120 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2025.

Based on Guardian Wealth Management (Illinois)'s 13F filing for Q2 2025, filed 14 Aug 2025.